Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$303M |
| 2 |
General Dynamics
GD
|
+$147M |
| 3 |
Cigna
CI
|
+$95.5M |
| 4 |
CVS Health
CVS
|
+$85.5M |
| 5 |
Marathon Petroleum
MPC
|
+$52.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$234M |
| 2 |
Northrop Grumman
NOC
|
+$218M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$170M |
| 4 |
PX
Praxair Inc
PX
|
+$168M |
| 5 |
COL
Rockwell Collins
COL
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.9% |
| 2 | Healthcare | 16.26% |
| 3 | Consumer Discretionary | 11.53% |
| 4 | Communication Services | 10.15% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HAPN
1801
Happen Inc
HAPN
$2.27B
| $1.38M | ﹤0.01% |
104,780
-2,400
| -2% | -$39.6K |
|
|
GTT
1802
DELISTED
GTT Communications, Inc.
GTT
| $1.37M | ﹤0.01% |
58,000
-4,100
| -7% | -$138K |
|
|
PRFT
1803
DELISTED
Perficient Inc
PRFT
| $1.37M | ﹤0.01% |
61,600
+1,200
| +2% | +$29.4K |
|
|
VRS
1804
DELISTED
Verso Corporation
VRS
| $1.37M | ﹤0.01% |
61,100
+1,500
| +3% | +$40.5K |
|
|
UNT
1805
DELISTED
UNIT Corporation
UNT
| $1.36M | ﹤0.01% |
95,600
+3,600
| +4% | +$77.8K |
|
|
AVX
1806
DELISTED
AVX Corporation
AVX
| $1.36M | ﹤0.01% |
89,500
+1,600
| +2% | +$25.8K |
|
1807
Cass Information Systems
CASS
$750M
| $1.36M | ﹤0.01% |
25,752
| – | – |
|
1808
Mativ Holdings
MATV
$667M
| $1.36M | ﹤0.01% |
54,400
+1,000
| +2% | +$30.8K |
|
|
BOLD
1809
DELISTED
Audentes Therapeutics, Inc
BOLD
| $1.36M | ﹤0.01% |
63,900
+20,300
| +47% | +$524K |
|
1810
Alamo Group
ALG
$1.99B
| $1.36M | ﹤0.01% |
17,600
+400
| +2% | +$33.3K |
|
1811
MBIA
MBI
$262M
| $1.36M | ﹤0.01% |
152,300
-3,500
| -2% | -$33.3K |
|
1812
E.W. Scripps
SSP
$310M
| $1.36M | ﹤0.01% |
86,716
-5,000
| -5% | -$83.5K |
|
1813
MGP Ingredients
MGPI
$389M
| $1.36M | ﹤0.01% |
23,800
+500
| +2% | +$33.8K |
|
1814
SiriusPoint
SPNT
$2.7B
| $1.36M | ﹤0.01% |
140,900
-8,800
| -6% | -$94.4K |
|
1815
Gates Industrial Corporation Ltd.
GTES
$7B
| $1.36M | ﹤0.01% |
102,500
+1,600
| +2% | +$24K |
|
1816
Chefs' Warehouse
CHEF
$4.57B
| $1.36M | ﹤0.01% |
42,400
+2,900
| +7% | +$101K |
|
1817
Helix Energy Solutions
HLX
$1.49B
| $1.35M | ﹤0.01% |
248,800
+4,500
| +2% | +$36.7K |
|
1818
PJT Partners
PJT
$4.57B
| $1.34M | ﹤0.01% |
34,535
+700
| +2% | +$31.4K |
|
|
RAD
1819
DELISTED
Rite Aid Corporation
RAD
| $1.34M | ﹤0.01% |
94,475
| – | – |
|
|
CSW
1820
CSW Industrials
CSW
$5.59B
| $1.34M | ﹤0.01% |
27,649
| – | – |
|
1821
Wabash National
WNC
$509M
| $1.34M | ﹤0.01% |
102,200
| – | – |
|
1822
TherapeuticsMD
TXMD
$24.1M
| $1.34M | ﹤0.01% |
7,020
+614
| +10% | +$150K |
|
1823
AngioDynamics
ANGO
$647M
| $1.33M | ﹤0.01% |
66,300
| – | – |
|
1824
Unitil
UTL
$992M
| $1.33M | ﹤0.01% |
26,300
-500
| -2% | -$24.9K |
|
|
CCF
1825
DELISTED
Chase Corporation
CCF
| $1.33M | ﹤0.01% |
13,300
+300
| +2% | +$32.3K |
|
Similar funds
Swiss National Bank's Q4 2018 Portfolio in Review
As of Q4 2018, Swiss National Bank held 2,591 positions worth $78B, down 13% from $89.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Swiss National Bank's Q4 2018 filing shows 87 new, 1,610 increased, 323 reduced and 55 closed positions. Its largest new stake was Linde: 1,915,836 shares worth $299M. The largest sale was Aetna Inc, an estimated $234M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q4 2018 buy was Linde: 1,915,836 shares worth $299M.
- Swiss National Bank added most to Cigna in Q4 2018, an estimated $95.5M increase.
- Swiss National Bank's biggest Q4 2018 reduction was Dell, cutting an estimated $52.3M.
- Swiss National Bank fully exited Aetna Inc in Q4 2018, selling an estimated $234M.
- Swiss National Bank's ten largest holdings make up 18% of its $78B portfolio in Q4 2018.
- Swiss National Bank opened 87 new positions and closed 55 in Q4 2018.
- Swiss National Bank's portfolio value fell 13% quarter-over-quarter to $78B.
Based on Swiss National Bank's 13F filing for Q4 2018, filed 13 Feb 2019.